# EP502: How Some Pretty Wild Medicare Fraud Sabotages ACOs and Also Independent Practices and Could Cost Plan Sponsors Such as Self-insured Employers a Lot of Zeros Downstream, With Brian Machut Page: https://stenobird.com/podcast/relentless-health-value-872220/ep502-how-some-pretty-wild-medicare-fraud-sabotages-acos-and-also-independent-practices-and-could-cost-plan-sponsors-such-as-self-insured-employers-a-lot-of-zeros-downstream-with-brian-machut Text version: https://stenobird.com/podcast/relentless-health-value-872220/ep502-how-some-pretty-wild-medicare-fraud-sabotages-acos-and-also-independent-practices-and-could-cost-plan-sponsors-such-as-self-insured-employers-a-lot-of-zeros-downstream-with-brian-machut.md Podcast: [Relentless Health Value](https://stenobird.com/podcast/relentless-health-value-872220) Published: 2026-03-05T11:30:00+00:00 Episode link: https://cc-lnk.com/EP502 Audio file: https://traffic.libsyn.com/secure/healthvalue/RHV_EP502_Brian_Machut.mp3?dest-id=197686 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/relentless-health-value-872220/episodes/ep502-how-some-pretty-wild-medicare-fraud-sabotages-acos-and-also-independent-practices-and-could-cost-plan-sponsors-such-as-self-insured-employers-a-lot-of-zeros-downstream-with-brian-machut Duration seconds: 2338 ## Resource Episode 502 features Stacey's conversation with Brian Machut (Alliant Health) on how widespread Medicare fee-for-service fraud is inflating costs and undermining ACO shared savings in MSSP and ACO REACH. ACOs uncovered major urinary catheter fraud in 2023 tied to codes A4352/A4353, totaling about $3.5B, with some beneficiaries billed for items never received (including a case shared by Dr. Tara Lagu). CMS created a "SAHS" (significant, anomalous, highly suspect) process to remove certain suspect costs, but benchmark effects can unevenly impact ACOs; catheter fraud is still projected at $3–$3.5B in 2025. The episode also highlights rapidly growing "skin substitute" spending projected at $13–$15B in 2025; CMS did not classify 2024 skin substitute costs as SAHS, leaving them in ACO performance calculations. Machut explains this fraud and missed CMS trend projections can reduce provider earnings, discourage participation in value-based care, and potentially drive cost shifting into higher commercial rates—affecting plan sponsors such as self-insured employers. === LINKS === 🔗 Show Notes with all mentioned links: https://cc-lnk.com/EP502 ✉️ Enjoy this podcast? Subscribe to the free weekly newsletter: https://relentlesshealthvalue.com/join-the-relentless-tribe 🫙 Support the podcast with a small donation to the Tip Jar: https://relentlesshealthvalue.com/join-the-relentless-tribe 🎤 Listen on Apple Podcasts https://podcasts.apple.com/us/podcast/feed/id892082003?ls=1 🎤 Listen on Spotify https://open.spotify.com/show/6UjgzI7bScDrWvZEk2f46b 📺 Subscribe to our YouTube channel https://www.youtube.com/@RelentlessHealthValue === CONNECT WITH THE RHV TEAM === ✭ LinkedIn https://www.linkedin.com/company/relentless-health-value/ ✭ Threads https://www.threads.net/@relentlesshealthvalue/ ✭… ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/relentless-health-value-872220/episodes/ep502-how-some-pretty-wild-medicare-fraud-sabotages-acos-and-also-independent-practices-and-could-cost-plan-sponsors-such-as-self-insured-employers-a-lot-of-zeros-downstream-with-brian-machut/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/relentless-health-value-872220/ep502-how-some-pretty-wild-medicare-fraud-sabotages-acos-and-also-independent-practices-and-could-cost-plan-sponsors-such-as-self-insured-employers-a-lot-of-zeros-downstream-with-brian-machut.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.